Kevin Martin1, Ioana D Olaru2, Nyasha Buwu3, Tsitsi Bandason3, Michael Marks4, Ethel Dauya3, Joice Muzangwa3, David Mabey4, Chido Dziva Chikwari2, Suzanna C Francis5, Mandikudza Tembo6, Constancia Mavodza7, Victoria Simms8, Constance R S Mackworth-Young4, Anna Machiha9, Katharina Kranzer10, Rashida A Ferrand2. 1. Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: kevinmartin@doctors.org.uk. 2. Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe. 3. Biomedical Research and Training Institute, Harare, Zimbabwe. 4. Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK. 5. Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. 6. Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. 7. Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Department of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK. 8. Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe. 9. AIDS and TB Unit, Ministry of Health and Child Care, Zimbabwe. 10. Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe; Division of Infectious and Tropical Medicine, Medical Centre of the University of Munich, Munich, Germany.
Abstract
BACKGROUND: The prevalence of sexually transmitted infections (STIs) among youth is high in sub-Saharan Africa. We investigated the uptake of testing for and prevalence of Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhoea) infections among youth in community-based settings in Zimbabwe, and explored the facilitators and barriers to testing. METHODS: This study was nested within a cluster randomised trial of community-based delivery of integrated HIV and sexual and reproductive health services for youth aged 16-24 years. Chlamydia and gonorrhoea testing via urine samples using the Xpert CT/NG test was offered in the four intervention clusters in Harare, Zimbabwe. Factors associated with testing uptake were investigated in a subset of participants (n=257) using hierarchical multivariate logistic regression. In-depth interviews with a separate purposively selected sample (n=26) explored facilitators and barriers to STI testing and partner notification and were analysed using thematic analysis. FINDINGS: Between June 1, 2019, and Jan 31, 2020, there were 6200 attendances by 4440 participants (78·2% women, 21·8% men) median age 20·3 (IQR 17·9-22·8) years. 1478 participants had 1501 tests done, and 248 tests were positive and 1253 tests were negative for chlamydia or gonorrhoea, or both. STI test uptake was 33·3% (95% CI 31·9-34·7), increasing from 11·7% in June, 2019, to 37·1% in January, 2020. The prevalence of chlamydia or gonorrhoea, or both, was 16·5% (95% CI 14·7-18·5; 248 of 1501), with only seven participants (3%) showing symptoms. The overall yield of testing was 4·0% (95% CI 3·5-4·5; 248 of 6200). Uptake was associated with having symptoms (adjusted odds ratio [OR] 14·8, 95% CI 1·66-132·07) and negatively associated with being single (adjusted OR 0·33, 95% CI 0·13-0·84) or having a boyfriend or girlfriend (adjusted OR 0·19, 95% CI 0·087-0·43) compared with being married, and being a student compared with being employed (adjusted OR 0·26, 95% CI 0·10-0·68). Perceived risk and symptoms of STIs were motivators for testing whereas misinformation, anticipated stigma, and concern about confidentiality were barriers. INTERPRETATION: The prevalence of chlamydia or gonorrhoea, or both, was high among youth but only a minority were symptomatic. Therefore most infections would remain untreated without access to STI testing. Provision of education, counselling, and confidentiality are essential to improve uptake and acceptability of STI testing. FUNDING: Wellcome Trust.
BACKGROUND: The prevalence of sexually transmitted infections (STIs) among youth is high in sub-Saharan Africa. We investigated the uptake of testing for and prevalence of Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhoea) infections among youth in community-based settings in Zimbabwe, and explored the facilitators and barriers to testing. METHODS: This study was nested within a cluster randomised trial of community-based delivery of integrated HIV and sexual and reproductive health services for youth aged 16-24 years. Chlamydia and gonorrhoea testing via urine samples using the Xpert CT/NG test was offered in the four intervention clusters in Harare, Zimbabwe. Factors associated with testing uptake were investigated in a subset of participants (n=257) using hierarchical multivariate logistic regression. In-depth interviews with a separate purposively selected sample (n=26) explored facilitators and barriers to STI testing and partner notification and were analysed using thematic analysis. FINDINGS: Between June 1, 2019, and Jan 31, 2020, there were 6200 attendances by 4440 participants (78·2% women, 21·8% men) median age 20·3 (IQR 17·9-22·8) years. 1478 participants had 1501 tests done, and 248 tests were positive and 1253 tests were negative for chlamydia or gonorrhoea, or both. STI test uptake was 33·3% (95% CI 31·9-34·7), increasing from 11·7% in June, 2019, to 37·1% in January, 2020. The prevalence of chlamydia or gonorrhoea, or both, was 16·5% (95% CI 14·7-18·5; 248 of 1501), with only seven participants (3%) showing symptoms. The overall yield of testing was 4·0% (95% CI 3·5-4·5; 248 of 6200). Uptake was associated with having symptoms (adjusted odds ratio [OR] 14·8, 95% CI 1·66-132·07) and negatively associated with being single (adjusted OR 0·33, 95% CI 0·13-0·84) or having a boyfriend or girlfriend (adjusted OR 0·19, 95% CI 0·087-0·43) compared with being married, and being a student compared with being employed (adjusted OR 0·26, 95% CI 0·10-0·68). Perceived risk and symptoms of STIs were motivators for testing whereas misinformation, anticipated stigma, and concern about confidentiality were barriers. INTERPRETATION: The prevalence of chlamydia or gonorrhoea, or both, was high among youth but only a minority were symptomatic. Therefore most infections would remain untreated without access to STI testing. Provision of education, counselling, and confidentiality are essential to improve uptake and acceptability of STI testing. FUNDING: Wellcome Trust.
Authors: Z Mike Chirenje; Nicholas Dhibi; H Hunter Handsfield; Elizabeth Gonese; Beth Tippett Barr; Lovemore Gwanzura; Ahmed S Latif; Dumisili Venessa Maseko; Ranmini S Kularatne; Mufuta Tshimanga; Peter H Kilmarx; Anna Machiha; Owen Mugurungi; Cornelis A Rietmeijer Journal: Sex Transm Dis Date: 2018-06 Impact factor: 2.830
Authors: Nazmul Alam; Eric Chamot; Sten H Vermund; Kim Streatfield; Sibylle Kristensen Journal: BMC Public Health Date: 2010-01-18 Impact factor: 3.295
Authors: Shaun L Barnabas; Smritee Dabee; Jo-Ann S Passmore; Heather B Jaspan; David A Lewis; Shameem Z Jaumdally; Hoyam Gamieldien; Lindi Masson; Etienne Muller; Venessa D Maseko; Nonhlanhla Mkhize; Zizipho Mbulawa; Anna-Lise Williamson; Clive M Gray; Thomas J Hope; Francesca Chiodi; Janan Dietrich; Glenda Gray; Linda-Gail Bekker Journal: Int J STD AIDS Date: 2017-12-04 Impact factor: 1.359
Authors: Marwan M Badawi; Maryam A SalahEldin; Alaa B Idris; Elfatih A Hasabo; Zeinab H Osman; Widad M Osman Journal: PLoS One Date: 2019-09-12 Impact factor: 3.240
Authors: Olivia T Van Gerwen; Rajesh Talluri; Andres F Camino; Leandro A Mena; Nicholas Chamberlain; Eric W Ford; Ellen F Eaton; Christina A Muzny Journal: Sex Transm Dis Date: 2022-03-01 Impact factor: 3.868
Authors: Kelvin L Sarenje; Owen Ngalamika; Margaret C Maimbolwa; Amon Siame; Sody M Munsaka; Geoffrey Kwenda Journal: BMC Infect Dis Date: 2022-08-12 Impact factor: 3.667